INVEX THERAPEUTICS LTD (IXC)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for IXC during the last 90 days, indicating Moderate trading activity

Latest IXC Signals
16/06/2026	BUY
08/04/2026	SELL
02/04/2026	BUY
IXC Share Price
Current Price	$0.095
52 Week High	$0.160
52 Week Low:	$0.075
Trading at (% of 52 Week High)	59.38%

Business Overview

Invex Therapeutics Ltd (ASX: IXC) is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases and cancer. The company primarily works on drugs designed to modulate the immune system to improve patient outcomes.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for INVEX THERAPEUTICS LTD (IXC) is supported by potential upside at a low price point, but overall confidence is limited due to lack of detailed financial data, market volatility, and sector-specific risks.

Latest  INVEX THERAPEUTICS LTD(IXC)   News